Yüklüyor......
Advances in chimeric antigen receptor T-cell therapy for B-cell non-Hodgkin lymphoma
B-cell non-Hodgkin lymphoma (B-NHL) is a group of heterogeneous disease which remains incurable despite developments of standard chemotherapy regimens and new therapeutic agents in decades. Some individuals could have promising response to standard therapy while others are unresponsive to standard c...
Kaydedildi:
| Yayımlandı: | Biomark Res |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8278776/ https://ncbi.nlm.nih.gov/pubmed/34256851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40364-021-00309-5 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|